Dr. Noseworthy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st Street SW
Rochester, MN 55905- Is this information wrong?
Education & Training
- Massachusetts General HospitalFellowship, Clinical Cardiac Electrophysiology, 2011 - 2012
- Massachusetts General HospitalFellowship, Cardiovascular Disease, 2007 - 2011
- Massachusetts General HospitalResidency, Internal Medicine, 2004 - 2007
- University of Toronto Faculty of MedicineClass of 2004
Certifications & Licensure
- AZ State Medical License 2020 - 2026
- WI State Medical License 2018 - 2025
- FL State Medical License 2020 - 2025
- WY State Medical License 2022 - 2024
- MN State Medical License 2013 - 2024
- NE State Medical License 2020 - 2024
- IA State Medical License 2018 - 2023
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
- Join now to see all
Clinical Trials
- Batch Enrollment for AI-Guided Intervention to Lower Neurologic Events in Unrecognized AF Start of enrollment: 2020 Nov 02
Publications & Presentations
PubMed
- Artificial intelligence-enabled electrocardiogram (AI-ECG) does not predict atrial fibrillation following patent foramen ovale closure.Baqal, O., Hasabo, E., Galasso, F., Habib, E., Barry, T., Arsanjani, R., Sweeney, J., Noseworthy, P., David Fortuin, F.> ;International Journal of Cardiology. Heart & Vasculature. 2024 Apr 1
- Regional differences in outcomes with ablation versus drug therapy for atrial fibrillation: Results from the CABANA trial.Riccardo Cappato, Daniel B Mark, Adam P Silverstein, Peter A Noseworthy, Gianluca Bonitta, Jeanne E Poole, Jonathan P Piccini, Tristram D Bahnson, Melanie R Daniels, H...> ;American Heart Journal. 2024 Apr 1
- Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes...James E Ip, Hanh Bui, A John Camm, Benoit Coutu, Peter A Noseworthy, Maria Leonor Parody, Samuel F Sears, Narendra Singh, Juan Agudelo Uribe, John Vyselaar, Sarah Omod...> ;American Heart Journal. 2024 Apr 1
- Join now to see all
Journal Articles
- Association of New-Onset Atrial Fibrillation After Noncardiac Surgery with Subsequent Stroke and Transient Ischemic AttackKonstantinos C Siontis, Bernard J Gersh, Peter A Noseworthy, JAMA
- Assessment of Shared Decision-Making for Stroke Prevention in Patients with Atrial FibrillationHaeshik Gorr, Takeki Suzuki, Erik Hess, Juan P Brito, Peter A Noseworthy, Victor M Montori, JAMA Internal Medicine
- Original Investigation Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus RhythmPeter A Noseworthy, Roger S Damle, Bruce S Stambler, Jose M Teixeira, Kenneth C Bilchick, Richard S Kuk, Pirouz Shamszad, ScienceDirect
- Join now to see all
Authored Content
- Association of New-Onset Atrial Fibrillation After Noncardiac Surgery with Subsequent Stroke and Transient Ischemic AttackSeptember 2020
- Left Atrial Appendage Occlusion and Surgical Ablation for Atrial Fibrillation During Cardiac Surgery—ReplyOctober 2018
Press Mentions
- AI Model Uses ECG Data to Identify New Cases of AFibOctober 3rd, 2022
- Big Data Dive Confirms Early Intervention Nets Better Outcomes for People with New Onset AFibJuly 27th, 2022
- Mayo Clinic Research Finds AI-Enabled ECGs May Identify Patients at Greater Risk of Stroke, Cognitive DeclineMay 2nd, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: